Tender detail
Tender for Ustekinumab medicinal products 103/2026
Summary
The tender concerns the supply of medicinal products containing Ustekinumab in two lots. The estimated total value is EUR 7,277,955, and the planned duration of each lot is 24 months. The tender submission deadline is 29 October 2026 at 13:00. Price is the only award criterion. Tenders must be submitted electronically; variants are not permitted, but bidders may submit for both lots. The tender must remain valid for six months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.